Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

Zepbound (tirzepatide) is an FDA-approved medication for weight management. People need a prescription to buy this medication, and several telemedicine companies offer doctor-led prescription and ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for ... there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

Take a look at this impressive weight loss transformation.Photo: Instagram/sushmita_weightloss Towards the end of 2023, Sushmita Gautam weighed 129 kg. While she had tried to lose weight multiple ...

(KCTV) - Weight loss drugs may have more benefits than some ... researchers analyzed Mounjaro, Zepbound, Ozempic, and Wegovy. These drugs are typically used to treat diabetes and obesity but ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

Lilly is launching two new doses and cutting prices for self-paying customers Eli Lilly & Co. said Tuesday it's cutting the price of single-dose vials of its Zepbound treatment for diabetes and ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... tirzepatide achieved at least 25% body weight loss compared to 16.1% of those receiving ...